Scleroderma After COVID-19 Infection and Vaccination

Authors

Henry Zou
Akash Rau
Steven Daveluy, Beaumont Health

Document Type

Article

Publication Date

9-29-2023

Publication Title

Skinmed

Abstract

Scleroderma is a rare autoimmune connective tissue disorder characterized by fibrotic hardening and tightening of the skin. Scleroderma develops as a drug-induced and paraneoplastic phenomenon; however, scleroderma associated with COVID-19 has been rarely discussed. We present an updated review of scleroderma after the COVID-19 infection and vaccination. Literature searches were conducted on MEDLINE (PubMed), Embase, Scopus, and Google Scholar from 2019 to January 2023. In all, 13 studies were selected based on the subject relevance, with screening of references contained in the selected papers. As of January 2023, we had four patients with scleroderma after the COVID-19 infection (M

Volume

21

Issue

4

First Page

253

Last Page

256

Recommended Citation

Zou H, Rau A, Daveluy S. Scleroderma after COVID-19 Infection and Vaccination. Skinmed. 2023 Sep 29;21(4):253-256. PMID: 37771015.

ISSN

1751-7125

PubMed ID

37771015